Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up

References

• Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology 2011;118:1881–1885.
   PubMed Web of Science ®Google Scholar
• Werdich XQ, Jakobiec FA, Singh AD, Kim IK. A review of advanced genetic testing for clinical prognostication in uveal melanoma. Semin Ophthalmol 2013;28:361–371.
   PubMed Web of Science ®Google Scholar
• Kivela T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Brit J Ophthalmol 2009;93:1129–1131.
   PubMed Web of Science ®Google Scholar
• Isager P, Ehlers N, Overgaard J. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas. Acta Ophthalmol Scan 2004;82:517–525.
   PubMedGoogle Scholar
• Bakalian S, Marshall JC, Logan P, Faingold D, Maloney S, Di CS, et al. Molecular pathways mediating liver metastasis in patients with uveal melanoma. Clin Cancer Res 2008;14:951–956.
   PubMed Web of Science ®Google Scholar
• Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E, et al. Survival in patients with uveal melanoma in Europe. Arch Ophthalmol 2008;126:1413–1418.
   PubMedGoogle Scholar
• Damato B, Eleuteri A, Taktak AFG, Coupland SE. Estimating prognosis for survival after treatment of choroidal melanoma. Prog Retin Eye Res 2011;30:285–295.
   PubMed Web of Science ®Google Scholar
• Woodman SE. Metastatic uveal melanoma: biology and emerging treatments. Cancer J 2012;18:148–152.
   PubMed Web of Science ®Google Scholar
• Chen X, Ai Z, Rasmussen M, Bajcsy P, Auvil L, Welge M, et al. Three-dimensional reconstruction of extravascular matrix patterns and blood vessels in human uveal melanoma tissue: techniques and preliminary findings. Invest Ophthalmol Vis Sci 2003;44:2834–2840.
   PubMed Web of Science ®Google Scholar
• Makitie T, Summanen P, Tarkkanen A, Kivela T. Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma. Invest Ophthalmol Vis Sci 2001;42:1414–1421.
   PubMed Web of Science ®Google Scholar
• Onken MD, Worley LA, Ehlers JP, Harbour JW. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 2004;64:7205–7209.
   PubMed Web of Science ®Google Scholar
• Harbour JW, Onken MD, Roberson ED, Duan S, Cao L, Worley LA, et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 2010;330:1410–1413.
   PubMed Web of Science ®Google Scholar
• Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, Vemula S, Wiesner T, et al. Mutations in GNA11 in uveal melanoma. N Engl J Med 2010;363:2191–2199.
   PubMed Web of Science ®Google Scholar
• Kujala E, Damato B, Coupland SE, Desjardins L, Bechrakis NE, Grange JD, et al. Staging of ciliary body and choroidal melanomas based on anatomic extent. J Clin Oncol 2013;31:2825–2831.
   PubMed Web of Science ®Google Scholar
• Kuo PK, Puliafito CA, Wang KM, Liu HS, Wu BF. Uveal melanoma in China. Int Ophthalmol Clin 1982;22:57–71.
   PubMedGoogle Scholar
• Carbone M, Yang H, Pass HI, Krausz T, Testa JR, Gaudino G. BAP1 and cancer. Nat Rev Cancer 2013;13:153–159.
   PubMed Web of Science ®Google Scholar
• Koopmans AE, Verdijk RM, Brouwer RW, van den Bosch TP, van den Berg MM, Vaarwater J, et al. Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma. Mod Pathol 2014;27:1321–1330.
   PubMed Web of Science ®Google Scholar
• Malignant melanoma of the uvea, in Edge SB,Byrd DR, Compton CC, et al (eds): AJCC Cancer Staging Manual (ed 7). New York, NY, Springer, 2010, pp 547–559.
   Google Scholar
• McLean IW, Foster WD, Zimmerman LE, Gamel JW. Modifications of Callender’s classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol 1983;96:502–509.
   PubMed Web of Science ®Google Scholar
• Sakamoto T, Sakamoto M, Yoshikawa H, Hata Y, Ishibashi T, Ohnishi Y, et al. Histologic findings and prognosis of uveal malignant melanoma in Japanese patients. Am J Ophthalmol 1996;121:276–283.
   PubMed Web of Science ®Google Scholar
• Albert DM, Diener-West M, Robinson NL, Grossniklaus HE, Green WR, Collab Ocular Melanoma Study, Grp. Histopathologic characteristics of uveal melanomas in eyes enucleated from the collaborative ocular melanoma study COMS report no 6. Am J Ophthalmol1998;125:745–766.
   PubMed Web of Science ®Google Scholar
• Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1973–1997. Ophthalmology 2003;110:956–961.
   PubMed Web of Science ®Google Scholar
• Damato BE, Coupland SE. Differences in uveal melanomas between men and women from the British Isles. Eye 2012;26:292–299.
   PubMed Web of Science ®Google Scholar
• Li B. Analysis of prognostic factors in malignant melanoma of the uveal tract. Chin J Ophthalmol 1990;26:270–274.
   Google Scholar
• Qu Y, Wang Y, Ma J, Zhang Y, Meng N, Li H, et al. Overexpression of high mobility group A1 protein in human uveal melanomas: implication for prognosis. PLoS One 2013;8:e68724.
   PubMed Web of Science ®Google Scholar
• Zhu R, Wei W, Li B, Xu X. The relationship between the prognosis and the clinical and pathological features of uveal melanomas. Chin J Ocul Fundus Dis 2011;27:435–439.
   Google Scholar
• Hong M, Wei W, Hua L, Xu X, Shao L. Clinical observation of local resection or enucleation for uveal melanoma. Chin Med J 2014;127:3459–3463.
   PubMed Web of Science ®Google Scholar
• Xu X, Wei WB, Li B, Gao F, Zhang Z, Jonas JB. Oncogenic GNAQ and GNA11 mutations in uveal melanoma in Chinese. PLoS One 2014;9:e109699.
   PubMed Web of Science ®Google Scholar
• Lee CS, Lee J, Choi JJ, Yang WI, Yoon JS, Lee SY, et al. Cytogenetics and prognosis for uveal melanoma in Korean patients. Acta Ophthalmol 2011;89:E310–E314.
   PubMed Web of Science ®Google Scholar
• Biswas J, Kabra S, Krishnakumar S, Shanmugam MP. Clinical and histopathological characteristics of uveal melanoma in Asian Indians. A study of 103 patients. Indian J Ophthalmol 2004;52:41–44.
   PubMedGoogle Scholar
• The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS report no. 10. Am J Ophthalmol 1998;125:779–796.
   PubMed Web of Science ®Google Scholar
• Hawkins BS. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24. Am J Ophthalmol 2004;138:936–951.
   Google Scholar
• Diener-West M, Earle JD, Fine SL, Hawkins BS, Moy CS, Reynolds SM, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol 2001;119:969–982.
   Google Scholar
• The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol 2006;124:1684–1693.
   PubMed Web of Science ®Google Scholar
• Al-Jamal RT, Cassoux N, Desjardins L, Damato B, Konstantinidis L, Coupland SE, et al. The pediatric choroidal and ciliary body melanoma study a survey by the european ophthalmic oncology group. Ophthalmology 2016;123:898–907.
   PubMed Web of Science ®Google Scholar